mendel mantoux-test
TRANSCRIPT
![Page 1: Mendel mantoux-test](https://reader036.vdocuments.us/reader036/viewer/2022062502/58a65e541a28ab1c5b8b5cd9/html5/thumbnails/1.jpg)
MENDEL-MANTOUX TEST
![Page 2: Mendel mantoux-test](https://reader036.vdocuments.us/reader036/viewer/2022062502/58a65e541a28ab1c5b8b5cd9/html5/thumbnails/2.jpg)
INDEX
1. Introduction
2. Procedure
3. Results
![Page 3: Mendel mantoux-test](https://reader036.vdocuments.us/reader036/viewer/2022062502/58a65e541a28ab1c5b8b5cd9/html5/thumbnails/3.jpg)
Introduction• Also known as the tuberculin
sensitivity test.• Screening tool for tuberculosis (TB)• Uses a Purified protein derivative (PPD)
tuberculin, a precipitate of glycerol molecules obtained from filtrates of sterilized and concentrated cultures of TB.
![Page 4: Mendel mantoux-test](https://reader036.vdocuments.us/reader036/viewer/2022062502/58a65e541a28ab1c5b8b5cd9/html5/thumbnails/4.jpg)
Procedure• A standard dose
consists of an intradermal injection of 0.1 ml solution for injection in the inner surface of the forearm
• Test is read 48 to 72 hours later.
• A person who has been exposed to the bacteria is expected to mount an immune response.
![Page 5: Mendel mantoux-test](https://reader036.vdocuments.us/reader036/viewer/2022062502/58a65e541a28ab1c5b8b5cd9/html5/thumbnails/5.jpg)
• The reaction is read by measuring the diameter of induration (palpable raised, hardened area) across the forearm in millimeters.
Erythema should not be measured
![Page 6: Mendel mantoux-test](https://reader036.vdocuments.us/reader036/viewer/2022062502/58a65e541a28ab1c5b8b5cd9/html5/thumbnails/6.jpg)
Results
Classification of reaction
![Page 7: Mendel mantoux-test](https://reader036.vdocuments.us/reader036/viewer/2022062502/58a65e541a28ab1c5b8b5cd9/html5/thumbnails/7.jpg)
Induration of 5 mm – 9 mm
• Persons with recent contacts with a TB patient
• Persons with nodular or fibrotic changes on chest X-ray consistent with old healed TB
• Patients with organ transplants, and other immunosuppressed patients
![Page 8: Mendel mantoux-test](https://reader036.vdocuments.us/reader036/viewer/2022062502/58a65e541a28ab1c5b8b5cd9/html5/thumbnails/8.jpg)
10 mm – 14 mm• Injection drug users• Residents and employees of high-risk congregate
settings (e.g., prisons, nursing homes, hospitals, homeless shelters, etc.)
• Persons with clinical conditions that place them at high risk (e.g., diabetes, prolonged corticosteroid therapy, leukemia, end-stage renal disease, chronic malabsorption syndromes, low body weight, etc.)
• Children less than four years of age, or children and adolescents exposed to adults in high-risk categories.
![Page 9: Mendel mantoux-test](https://reader036.vdocuments.us/reader036/viewer/2022062502/58a65e541a28ab1c5b8b5cd9/html5/thumbnails/9.jpg)
15 mm or more • Persons with no known risk factors for TB
![Page 10: Mendel mantoux-test](https://reader036.vdocuments.us/reader036/viewer/2022062502/58a65e541a28ab1c5b8b5cd9/html5/thumbnails/10.jpg)
False positive result
• Those who have received a BCG vaccine. Interpreted as latent TB infection.
• May be caused by a non-tuberculous mycobacteria.
• Another source of false positive results can be allergic reaction or hypersensitivity.
![Page 11: Mendel mantoux-test](https://reader036.vdocuments.us/reader036/viewer/2022062502/58a65e541a28ab1c5b8b5cd9/html5/thumbnails/11.jpg)
False negative result
• Infectious mononucleosis• Anergy • Live virus vaccine - The test should not be
carried out within 3 weeks of live virus vaccination.
• Sarcoidosis• Hodgkin's disease• Corticosteroid therapy/Steroid use• Malnutrition• Immunologically compromised
![Page 12: Mendel mantoux-test](https://reader036.vdocuments.us/reader036/viewer/2022062502/58a65e541a28ab1c5b8b5cd9/html5/thumbnails/12.jpg)
THANK YOU